ciclopirox olamine (E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the ciclopirox olamine drug offered from E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc.. This Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | ciclopirox olamine |
| SUBSTANCE NAME: | CICLOPIROX OLAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2004-12-29 |
| END MARKETING DATE: | 0000-00-00 |
ciclopirox olamine HUMAN PRESCRIPTION DRUG Details:
| Item Description | ciclopirox olamine from E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. |
| LABELER NAME: | E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.7(mg/g) |
| START MARKETING DATE: | 2004-12-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0168-0313_2c9efbd4-8a94-4331-b8b3-271d3036e2ff |
| PRODUCT NDC: | 0168-0313 |
| APPLICATION NUMBER: | ANDA076435 |
Other CICLOPIROX OLAMINE Pharmaceutical Manufacturers / Labelers:
